These mechanisms include inhibiting the buildup of Aβ plaques, enhancing gut microbial balance, restoring the impaired intestinal barrier, and possibly suppressing the TLR4/NF-κB/NLRP3 pathway to decrease inflammation of AD. This evidence concerns the gene NLRP3 and Alzheimer disease.